Telios Pharmaceuticals Overview

  • Founded
  • 1987
  • Status
  • Public

Telios Pharmaceuticals General Information


Developer of products for the treatment of wounds, fibrotic disease, cardiovascular disease and osteoporosis. The company applies its proprietary technology to develop products for the treatment of severe and chronic dermal wounds, ophthalmic wounds, fibrotic disease, liver cirrhosis, acute respiratory distress syndrome, cardiovascular disease and osteoporosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 4757 Nexus Centre Drive
  • San Diego, CA 92121
  • United States
+1 (619) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Telios Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Telios Pharmaceuticals‘s full profile, request access.

Request a free trial

Telios Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
David Duncan Chief Financial Officer & Vice President, Finance
Richard Kaufman JD Vice President & Secretary
To view Telios Pharmaceuticals’s complete executive team members history, request access »